VisualOcuity Drops - NAC Eye Drops

These are currently Out of Stock.

Visual Acuity Eye Drops were specifically designed to support healthy eye function. Unlike most body tissues, the lens of the eye does not experience cellular turnover, the eye cells we're born with are the ones we have for life.

Common Threats to Eye Health

A wide range of factors can damage these irreplaceable cells, including:

• Environmental hazards (smoke, dust, ultraviolet rays)
• Lifestyle factors (excessive sugars, drug use)
• Health conditions (inadequate nutrient levels, poor blood flow)

These factors can lead to serious conditions such as cataracts, glaucoma, retinal/macular degeneration, corneal disorders, ocular inflammation, and diabetic complications.

The Science Behind NAC

Visual Acuity contains N-Acetyl-Carnosine (NAC), a time-release form of the naturally occurring dipeptide L-Carnosine—a powerful antioxidant. This specialized form of L-Carnosine can access both the aqueous and lipid portions of the eye, providing comprehensive protection and support*.

Research Results

Both human and animal studies have shown remarkable results with NAC treatment. Dr. Babizhayev, one of the leading NAC researchers, reported impressive findings from animal studies:

"The NAC anti-cataract drops have been carefully tested in animals... The most striking results have been obtained using a 1% NAC instillation in canines. The cortical appearance of cataract reversal starts from the periphery and then the lens becomes more transparent. This is then accompanied by the improved visual behavior of the animal."

Human Clinical Studies

Dr. Babizhayev's human trials showed equally promising results. Compared to a control group that showed gradual deterioration over 24 months, patients treated with NAC eye drops demonstrated significant improvements:

• 41.5% of treated eyes showed 7-100% improvement in visual acuity at 6 months
• 88.9% of treated eyes showed 27-100% improvement in glare sensitivity

These results highlight NAC's potential as a breakthrough treatment for age-related eye conditions.